Tag Archives | VRX

Governance and the Valeant Flea

ValeantGovernance and the Valeant Flea: The Art of Not Living Dangerously

“You may well say, that’s a valiant flea that dare eat his breakfast on the lip of a lion.”

-William Shakespeare

Valeant: Cautionary Tale

There’s a good reason that no bestselling novels or blockbuster movies about corporate governance exist. It’s because doing corporate governance right is frankly boring. Figuring out which companies are well governed is not a beautiful or riveting process, but for investors it’s critical to make the effort. Why? Because identifying companies that are skating too near the edge may help preserve portfolio value. At Pax World, we experienced this first-hand when we eliminated the drug company Valeant (VRX) from our portfolios last fall. Continue Reading →

Continue Reading ·

Valeant Pharmaceuticals International (VRX): How I Voted – Proxy Score 33 Revised 5/24/2012

Valeant (VRX) ($VRX) is one of the stocks in my portfolio. Their annual meeting is coming up on 5/30/2012. Voting ends 5/29 on Moxy Vote’s proxy voting platform, which had 3 recommendations “from good causes” when I checked and voted on 5/23 but 2 were consolidations of the one. ProxyDemocracy.org had 0 funds voting.  I voted with management 33% of the time. Continue Reading →

Continue Reading ·

Powered by WordPress. Designed by WooThemes